Collect

One 5.0 mL EDTA (Lavendar) tube. 5.0 mL of blood or 3.0 mL minimum.



Must include CBC order or results on a specimen collected at the same time as the specimen for the lymphocyte testing. 

Unacceptable Conditions

The specimen will be considered unacceptable if it is clotted, hemalyzed, centrifuged, received in the lab over 72 hours from collection, or no CBC results performed on a specimen collected the same time as the specimen for the assay.

Storage/Transport Temperature

Ambient

Stability (from collection to initiation)

Specimen should be received in the lab within 24 hours of collection.  If specimen is greater than 24-72 hours, a CBC result performed on a specimen collected at the same time MUST accompany specimen.

Performed

Flow Cytometry Laboratory.  Monday-Friday (Specimens must be received by 1100 on Friday).

Performed

Flow Cytometry Laboratory.  Monday-Friday (Specimens must be received by 1100 on Friday).

Reported

Monday through Friday:  Results in 48 hours

Reference Interval

 0-3 mo3-6 mo6-12 mo1-2 yr2-5 yr6-11 yr12-18 yr>19 year
 %/cmm%/cmm%/cmm%/cmm%/cmm%/cmm%/cmm%/cmm
CD353-842500-550051-772500-560049-761900-590053-752100-620056-751400-370060-761200-260056-841000-220061.0-88.6427-3455
CD196-32300-200011-41430-300014-37610-260016-35720-260014-33390-140013-27270-8606-2370-4803.0-25.821-1006
CD202.0-10.0% (18-310/cmm)

CPT Codes

86359,86355

Test Build Information

Italic font means the result will only be reported if there is a value.
OrderCodeOrderNameResultCodeResultNameResult UnitsLOINCCPT
RITUXRITUXAN THERAPY PANLIWBCWHITE BLOOD COUNT 20584-986355, 86359
RITUXRITUXAN THERAPY PANLILYMLYMPHOCYTES   ( %)   61123-6 
RITUXRITUXAN THERAPY PANLCD3PQPERCENT CD3   20599-7 
RITUXRITUXAN THERAPY PANLCD3NQCD3 ( /CMM)   20598-9 
RITUXRITUXAN THERAPY PANLC19PQCD19 (% 8117-4 
RITUXRITUXAN THERAPY PANLC19NQCD19 ( /CMM)   8116-6 
RITUXRITUXAN THERAPY PANLCD20PCD20 (%)   20595-5 
RITUXRITUXAN THERAPY PANLCD20NCD20 (/CMM) 9558-8 
RITUXRITUXAN THERAPY PANLTERP1INTERPRETATION 50595-8 

Example Report

Additional Information

For additional information or questions, contact RPSInterfaceSupport@unmc.edu
 
Collection

Collect

One 5.0 mL EDTA (Lavendar) tube. 5.0 mL of blood or 3.0 mL minimum.



Must include CBC order or results on a specimen collected at the same time as the specimen for the lymphocyte testing. 

Unacceptable Conditions

The specimen will be considered unacceptable if it is clotted, hemalyzed, centrifuged, received in the lab over 72 hours from collection, or no CBC results performed on a specimen collected the same time as the specimen for the assay.

Storage/Transport Temperature

Ambient

Stability (from collection to initiation)

Specimen should be received in the lab within 24 hours of collection.  If specimen is greater than 24-72 hours, a CBC result performed on a specimen collected at the same time MUST accompany specimen.

Performed

Flow Cytometry Laboratory.  Monday-Friday (Specimens must be received by 1100 on Friday).

Ordering

Performed

Flow Cytometry Laboratory.  Monday-Friday (Specimens must be received by 1100 on Friday).

Reported

Monday through Friday:  Results in 48 hours

Result Interpretation

Reference Interval

 0-3 mo3-6 mo6-12 mo1-2 yr2-5 yr6-11 yr12-18 yr>19 year
 %/cmm%/cmm%/cmm%/cmm%/cmm%/cmm%/cmm%/cmm
CD353-842500-550051-772500-560049-761900-590053-752100-620056-751400-370060-761200-260056-841000-220061.0-88.6427-3455
CD196-32300-200011-41430-300014-37610-260016-35720-260014-33390-140013-27270-8606-2370-4803.0-25.821-1006
CD202.0-10.0% (18-310/cmm)
Administrative

CPT Codes

86359,86355
RPS Interface Information

Test Build Information

Italic font means the result will only be reported if there is a value.
OrderCodeOrderNameResultCodeResultNameResult UnitsLOINCCPT
RITUXRITUXAN THERAPY PANLIWBCWHITE BLOOD COUNT 20584-986355, 86359
RITUXRITUXAN THERAPY PANLILYMLYMPHOCYTES   ( %)   61123-6 
RITUXRITUXAN THERAPY PANLCD3PQPERCENT CD3   20599-7 
RITUXRITUXAN THERAPY PANLCD3NQCD3 ( /CMM)   20598-9 
RITUXRITUXAN THERAPY PANLC19PQCD19 (% 8117-4 
RITUXRITUXAN THERAPY PANLC19NQCD19 ( /CMM)   8116-6 
RITUXRITUXAN THERAPY PANLCD20PCD20 (%)   20595-5 
RITUXRITUXAN THERAPY PANLCD20NCD20 (/CMM) 9558-8 
RITUXRITUXAN THERAPY PANLTERP1INTERPRETATION 50595-8 

Example Report

Additional Information

For additional information or questions, contact RPSInterfaceSupport@unmc.edu